Rchr
J-GLOBAL ID:201601012604496324   Update date: Sep. 16, 2024

Yano Mitsutake

ヤノ ミツタケ | Yano Mitsutake
Affiliation and department:
Job title: Assistant professor
Research field  (3): Human pathology ,  Obstetrics and gynecology ,  Tumor biology
Research keywords  (5): Ovarian cancer ,  Endometrial cancer ,  Immunohistochemistry ,  ARID1A ,  Histone deacetylase
Research theme for competitive and other funds  (12):
  • 2022 - 2025 子宮体癌における免疫組織化学的パネルを用いた予後予測と再分類
  • 2021 - 2024 卵巣癌における低酸素誘導因子(HIF)の抑制機構の解明と治療応用への試み
  • 2019 - 2023 機能性間質に着目した,卵巣癌における腫瘍間質の起源・役割の解明
  • 2018 - 2023 卵巣癌における,低酸素関連因子の発現からみた組織型の意義:化学療法抵抗性の分別化
  • 2022 - 2023 Efficacy of HDAC6 inhibitors via Hippo pathway in ovarian clear cell carcinoma
Show all
Papers (52):
  • Junya Nakajima, Mitsutake Yano, Sumika Zaitsu, Kouichi Kamada, Akira Yabuno, Kosei Hasegawa, Eiji Kobayashi, Masanori Yasuda. Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma. Human pathology. 2024. 152. 105649-105649
  • Sumika Zaitsu, Yoko Aoyagi, Haruto Nishida, Kohei Nakamura, Mitsutake Yano, Eiji Kobayashi. Genetic Profiling of Sebaceous Carcinoma Arising from an Ovarian Mature Teratoma: A Case Report. International journal of molecular sciences. 2024. 25. 12
  • Oyama Y, Kusaba T, Takao K, Obata E, Yano M, Kawamura K, Haruto Nishida, Daa T. Alpha-fetoprotein producing endometrioid carcinoma arising in an adenomyoma of the uterus. Medical molecular morphology. 2024
  • Konishi K, Okamoto M, Tokumitsu R, Mitsutake Yano, Nasu K, Kobayashi E. Usage of nivolumab and ipilimumab for recurrent or advanced malignant vaginal melanoma: a two-case series. Medical molecular morphology. 2024
  • Sato M, Kaei Nasu, Matsumoto H, Konishi K, Yasumi S, Sato Y, Yano M, Kobayashi E. Extragonadal recurrence of benign mature teratoma in the pouch of Douglas. Asian journal of endoscopic surgery. 2023
more...
Books (9):
  • 【子宮I-子宮頸部-】子宮頸癌のゲノム異常と新しい治療法
    病理と臨床・文光堂 2023
  • 【悪性腫瘍の早期発見に必要な細胞診の目を養う】早期発見に必要な目の付け所 婦人科
    Medical Technology 医歯薬出版株式会社 2022
  • 【図解 分子メカニズムから理解する婦人科がんの薬物療法】臓器横断的な考え方を要する婦人科悪性腫瘍 悪性黒色腫
    産婦人科の実際・金原出版 2021
  • 【卵巣上皮系腫瘍update】悪性度評価の考察
    病理と臨床・文光堂 2020
  • 【免疫組織化学 実践的な診断・治療方針決定のために】(第3部)腫瘍の鑑別に用いられる抗体(各臓器別) 女性生殖器 子宮
    病理と臨床・文光堂 2020
more...
Lectures and oral presentations  (77):
  • 抗体薬物複合体ADCの適応を見据えた子宮体癌におけるHER2とp53の発現解析(Analysis of HER2 and p53 expression in endometrial carcinomas for treatment to ADC)
    (日本病理学会会誌 2024)
  • COVID-19治癒後の後遺症としての咳嗽によって腹部創部離開をきたした1例
    (産婦人科手術 2023)
  • 子宮頸部扁平上皮癌における HPVジェノタイピングの意義
    (2023)
  • 当講座における研究指導を通じたリクルート活動とその現状
    (2023)
  • 子宮内膜癌間質におけるperiostin発現の臨床病理学的検討
    (日本病理学会会誌 2023)
more...
Education (2):
  • 2016 - 2019 Saitama Medical University International Medical Center Department of Diagnostic Pathology
  • 2004 - 2010 Oita University
Professional career (2):
  • MD (Oita University)
  • PhD (Saitama Medical University)
Work history (8):
  • 2023/10 - 現在 The University of Texas MD Anderson Cancer Center Department of Experimental Therapeutics Postdoctoral Fellow
  • 2020 - 2024 Oita University Department of Ob-Gyn Assistant Professor
  • 2019 - 2020 Nakatsu Municipal Hospital Department of Ob-Gyn Medical Director
  • 2016 - 2019 Saitama Medical University International Medical Center Department of Diagnostic Pathology Assistant Professor
  • 2015 - 2016 Oita University Department of Ob-Gyn
Show all
Committee career (6):
  • 2023 - 現在 大分県臨床細胞学会 理事
  • 2023 - 現在 Japanese Society of Gynecologic Pathology 学術担当支援委員
  • 2023 - 現在 Japanese Society of Clinical Cytology 評議員
  • 2022 - 現在 日本婦人科腫瘍学会 子宮頸部コルポ小委員会 委員
  • 2022 - 現在 The Japanese Society for Clinical Molecular Morphology 評議員
Show all
Awards (8):
  • 2024 - Trainee Research Day 2024 Poster Award, UT MD Anderson Cancer Center
  • 2023 - Alumni Association Award, Department of Ob-Gyn, Oita University Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)
  • 2023 - ESMO Gynaecological Cancers Congress Travel Grant for the ESMO Gynaecological Cancers Congress 2023 PD-L1 expression following neoadjuvant chemotherapy is upregulated and serves as a prognostic factor in patients with advanced high-grade serous ovarian carcinoma.
  • 2023 - Japanese Society of Clinical Molecular Morphology Academic Encouragement Award
  • 2022 - The Japan Society of Obstetrics and Gynecology JSOG Congress Award
Show all
Association Membership(s) (6):
The Japanese Society for Clinical Molecular Morphology ,  The Japanese Society of Pathology ,  The Japanese Society of Gynecologic Pathology ,  The Japanese Society of Clinical Cytology ,  The Japan Society of Gynecologic Oncology ,  The Japan Society of Obstetrics and Gynecology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page